INPP5E
Phosphatidylinositol polyphosphate 5-phosphatase type IV
Also known as: CORS1, INP5E_HUMAN, JBTS1, pharbin, PPI5PIV
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NRR6
- Gene
- INPP5E
- Ensembl
- ENSG00000148384
- Chromosome
- 9
- Canonical length
- 644 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus,Focal adhesion sites
OverviewNCBI Gene
The protein encoded by this gene is an inositol 1,4,5-trisphosphate (InsP3) 5-phosphatase. InsP3 5-phosphatases hydrolyze Ins(1,4,5)P3, which mobilizes intracellular calcium and acts as a second messenger mediating cell responses to various stimulation. Studies of the mouse counterpart suggest that this protein may hydrolyze phosphatidylinositol 3,4,5-trisphosphate and phosphatidylinositol 3,5-bisphosphate on the cytoplasmic Golgi membrane and thereby regulate Golgi-vesicular trafficking. Mutations in this gene cause Joubert syndrome; a clinically and genetically heterogenous group of disorders characterized by midbrain-hindbrain malformation and various associated ciliopathies that include retinal dystrophy, nephronophthisis, liver fibrosis and polydactyly. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2016]
Canonical amino-acid sequenceUniProt
644 residues, UniProt reviewed canonical sequence.
>Q9NRR6|INPP5E
1 MPSKAENLRP SEPAPQPPEG RTLQGQLPGA PPAQRAGSPP DAPGSESPAL ACSTPATPSG
61 EDPPARAAPI APRPPARPRL ERALSLDDKG WRRRRFRGSQ EDLEARNGTS PSRGSVQSEG
121 PGAPAHSCSP PCLSTSLQEI PKSRGVLSSE RGSPSSGGNP LSGVASSSPN LPHRDAAVAG
181 SSPRLPSLLP PRPPPALSLD IASDSLRTAN KVDSDLADYK LRAQPLLVRA HSSLGPGRPR
241 SPLACDDCSL RSAKSSFSLL APIRSKDVRS RSYLEGSLLA SGALLGADEL ARYFPDRNVA
301 LFVATWNMQG QKELPPSLDE FLLPAEADYA QDLYVIGVQE GCSDRREWET RLQETLGPHY
361 VLLSSAAHGV LYMSLFIRRD LIWFCSEVEC STVTTRIVSQ IKTKGALGIS FTFFGTSFLF
421 ITSHFTSGDG KVAERLLDYT RTVQALVLPR NVPDTNPYRS SAADVTTRFD EVFWFGDFNF
481 RLSGGRTVVD ALLCQGLVVD VPALLQHDQL IREMRKGSIF KGFQEPDIHF LPSYKFDIGK
541 DTYDSTSKQR TPSYTDRVLY RSRHKGDICP VSYSSCPGIK TSDHRPVYGL FRVKVRPGRD
601 NIPLAAGKFD RELYLLGIKR RISKEIQRQQ ALQSQNSSTI CSVSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against INPP5E can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 22 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 22 nTPM
- spleen: 20 nTPM
- testis: 20 nTPM
- cerebral cortex: 17 nTPM
- ovary: 16 nTPM
- fallopian tube: 16 nTPM
Single-cell type
- fallopian tube ciliated cells: 27 nCPM
- ependymal cells: 21 nCPM
- respiratory ciliated cells: 20 nCPM
- astrocytes: 19 nCPM
- bergmann glia: 17 nCPM
- differentiating spermatogonia: 15 nCPM
Immune cell
- memory B-cell: 0.7 nTPM
- T-reg: 0.7 nTPM
- memory CD4 T-cell: 0.6 nTPM
- eosinophil: 0.5 nTPM
- gdT-cell: 0.5 nTPM
- memory CD8 T-cell: 0.4 nTPM
Brain region
- cerebral cortex: 32 nTPM
- pons: 27 nTPM
- cerebellum: 27 nTPM
- medulla oblongata: 27 nTPM
- amygdala: 26 nTPM
- thalamus: 26 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about INPP5E.
Disease | AllUniProt
Conditions INPP5E is implicated in, by any mechanism.
- Joubert syndrome 1 (JBTS1) MIM:213300
- Impaired intellectual development, truncal obesity, retinal dystrophy, and micropenis (MORMS) MIM:610156
Disease | GeneticClinVar
79 pathogenic / likely-pathogenic of 944 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Joubert syndrome
- Joubert syndrome 1
- MORM syndrome
- Joubert syndrome and related disorders
- INPP5E-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.68
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.51
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cilium assembly
- negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- negative regulation of protein localization to cilium
- negative regulation of translation
- phosphatidylinositol biosynthetic process
- phosphatidylinositol dephosphorylation
- response to inositol
Molecular functions
- inositol-polyphosphate 5-phosphatase activity
- phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity
- phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity
- phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity
- phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Inositol polyphosphate-related phosphatase
- Endonuclease/exonuclease/phosphatase superfamily
- Endonuclease/Exonuclease/phosphatase family 2
- 72kDa inositol polyphosphate 5-phosphatase
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of INPP5E in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads INPP5E as an antibody target. Whether an autoantibody or antibody against INPP5E could matter depends on whether native INPP5E is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
INPP5E is annotated at the cell surface, where native INPP5E is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label INPP5E as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...